This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Drotar, D.
Right arrow Articles by Kiziri-Mayengo, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Drotar, D.
Right arrow Articles by Kiziri-Mayengo, R.
Related Collections
Right arrow Infectious Disease & Immunity
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

PEDIATRICS Vol. 100 No. 1 July 1997, p. e5
Copyright ©1997 by the American Academy of Pediatrics

ELECTRONIC ARTICLE:
Neurodevelopmental Outcomes of Ugandan Infants With Human Immunodeficiency Virus Type 1 Infection

Received Sep 3, 1996; accepted Jan 14, 1997.

Dennis Drotar*, Karen Olness*, Max Wiznitzer*, Laura GuayDagger , Lawrence MarumDagger , Grace Svilar*, David Hom*, Joseph F. Fagan*, Christopher Ndugwa§, and Rebecca Kiziri-Mayengo§

From the * Departments of Pediatrics, Epidemiology, and Psychology, Case Western Reserve University, Cleveland, Ohio; Dagger  Johns Hopkins University, Baltimore, Maryland; and the § Departments of Pediatrics, Child Health, and Psychology, Makerere University, Kampala, Uganda.

Background.  The neurodevelopmental outcomes of human immunodeficiency virus type 1 (HIV-1)-infected Ugandan infants of nondrug-using mothers were studied using controlled, prospective methodology.

Method.  The sample of 436 full-term infants included 79 HIV-infected infants of HIV-1-infected mothers, 241 uninfected infants of HIV-1-infected mothers (seroreverters), and 116 uninfected infants born to HIV-negative mothers. Neurologic status, information processing ability, and motor and mental development were assessed from 6 to 24 months of age. Observations of caretaker-child interaction and home environments were made at 6 and 12 months. All evaluators were blinded to the HIV status of the child and family.

Results.  Compared with seroreverters and uninfected infants, HIV-infected infants demonstrated greater deficits in motor development and neurologic status, and more frequent and earlier onset of motor and neurologic abnormalities. Compared with controls, HIV-infected infants had more abnormalities in mental development at 6 and 18 months and an earlier onset of abnormalities. By 12 months, 30% of HIV-infected infants demonstrated motor abnormalities and 26% cognitive abnormalities as compared with 11% and 6% among seroreverters and 5% and 6% among seronegative infants. HIV-infected infants (62%) demonstrated a higher probability of developing an abnormal neurologic examination by 12 months, compared with seroreverters (17%) or seronegative infants (15%). Information-processing abilities did not differ as a function of HIV infection. Home environments and infants' interactions with caretakers were similar across groups.

Conclusion.  We conclude that HIV infection results in more frequent and earlier abnormalities in infants' neurologic status and motor development that are not attributable to other biological and environmental risk factors. More frequent mental developmental abnormalities were evident at several ages. However, information-processing abilities, such as recognition memory, may be spared from HIV-related deficits.

Key words: HIV infection, neurodevelopment, mental development, motor development, neurological status, information processing ability.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
EDUCATION AND PRACTICEHome page
J E. Harrop
Management of pain in childhood
Arch. Dis. Child. Ed. Pract., August 1, 2007; 92(4): ep101 - ep108.
[Full Text] [PDF]


Home page
Arch Pediatr Adolesc MedHome page
M. C. Shanbhag, R. M. Rutstein, T. Zaoutis, H. Zhao, D. Chao, and J. Radcliffe
Neurocognitive Functioning in Pediatric Human Immunodeficiency Virus Infection: Effects of Combined Therapy
Arch Pediatr Adolesc Med, July 1, 2005; 159(7): 651 - 656.
[Abstract] [Full Text] [PDF]


Home page
AAP NewsHome page
C. S. Houck
Taking `ouch' out of doctor visits easier than ever
AAP News, August 1, 2004; 25(2): 66 - 66.
[Full Text] [PDF]